Patent Assignment
Reel/Frame 048632/0099
Assignment of Assignor's Interest
Recorded: 2019-03-19
Pages: 5
Assignor
ALBELDA, STEVEN
Executed: 2018-11-13
Assignee
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
3160 CHESTNUT STREET, SUITE 200, PHILADELPHIA, PENNSYLVANIA, 19104
Covered Properties
(3)
Immuno-Gene Combination Therapy
Application:
15/672,330 →
Publication:
US 2019/0060313
Immuno-Gene Combination Therapy
Application:
16/268,548 →
Publication:
US 2019/0167690
PILOT AND FEASIBILITY CLINICAL TRIAL EVALUATING IMMUNO-GENE THERAPY OF MALIGNANT PLEURAL MESOTHELIOMA (MPM) USING INTRAPLEURAL DELIVERY OF ADENOVIRUS- INTERFERON-ALPHA (Ad.hIFN-ALPHA2b) IN COMBINATION WITH HIGH-DOSE CELECOXIB AND SYSTEMIC CHEMOTHERAPY
Application:
62/304,233 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmatory License
Jun 1, 2020
From: UNIVERSITY OF PENNSYLVANIA
To: NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR
Reel/Frame 052802/0462 →
Security Interest
Nov 19, 2020
From: TRIZELL LTD.
To: PHARMACEUTICAL PATENT ATTORNEYS, LLC
Reel/Frame 054775/0546 →
Release of Security Interest
Jan 31, 2022
From: PHARMACEUTICAL PATENT ATTORNEYS, LLC
To: TRIZELL LTD., F/K/A FINVECTOR LTD. F/K/A ARK THERAPEUTICS LTD.
Reel/Frame 058826/0044 →
Confirmatory License
Feb 3, 2022
From: UNIVERSITY OF PENNSYLVANIA
To: NIH - DEITR
Reel/Frame 058879/0059 →